HomeITRM • NASDAQ
add
Iterum Therapeutics PLC
Previous close
$0.82
Day range
$0.83 - $0.87
Year range
$0.66 - $3.02
Market cap
38.54M USD
Avg Volume
1.00M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.18M | 30.38% |
Net income | -6.51M | -30.26% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -5.18M | -30.49% |
Effective tax rate | -0.91% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.03M | 11.17% |
Total assets | 34.01M | 139.97% |
Total liabilities | 37.90M | 51.08% |
Total equity | -3.89M | — |
Shares outstanding | 44.66M | — |
Price to book | -9.11 | — |
Return on assets | -41.27% | — |
Return on capital | -47.53% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -6.51M | -30.26% |
Cash from operations | -4.75M | 29.71% |
Cash from investing | 0.00 | -100.00% |
Cash from financing | 5.12M | 2,965.87% |
Net change in cash | 374.00K | 115.50% |
Free cash flow | -2.39M | 53.05% |
About
Founded
2015
Website
Employees
9
